Statements (58)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:disease
|
| gptkbp:affects |
organs
|
| gptkbp:associated_with |
gptkb:Oncology
gptkb:cardiac_amyloidosis chronic inflammatory diseases systemic amyloidosis localized amyloidosis neuropathic amyloidosis renal amyloidosis |
| gptkbp:caused_by |
abnormal protein folding
|
| gptkbp:complication |
heart failure
kidney damage gastrointestinal issues liver enlargement nervous system issues |
| gptkbp:diagnosis |
blood tests
urine tests imaging studies biopsy |
| gptkbp:first_described_by |
1860s
|
| https://www.w3.org/2000/01/rdf-schema#label |
Amyloidosis
|
| gptkbp:prevalence |
rare disease
|
| gptkbp:research_focus |
environmental factors
patient outcomes genetic factors treatment efficacy diagnostic methods protein misfolding amyloid deposits |
| gptkbp:risk_factor |
age
chronic diseases family history genetic mutations |
| gptkbp:symptoms |
fatigue
weight loss swelling |
| gptkbp:treatment |
gptkb:immunotherapy
palliative care clinical trials antioxidants physical therapy supportive care lifestyle changes monoclonal antibodies chemotherapy pain management anti-inflammatory drugs stem cell transplant dietary modifications hormonal therapy experimental therapies antifibrillogenic agents |
| gptkbp:type |
gptkb:neurodegenerative_diseases
gptkb:AL_amyloidosis ATTR amyloidosis AA amyloidosis |
| gptkbp:bfsParent |
gptkb:Multiple_Myeloma
|
| gptkbp:bfsLayer |
7
|